TFAP4 and posterior cortical atrophy: Therefore, understanding the precise regulatory mechanism of AP4 in PCa progression will not only advance our knowledge of the tumourigenesis of PCa but will also permit the development of novel therapeutic strategies and help identify an effective biomarker to predict outcomes for PCa patients.